Search research articles
Contact Us
Filters
Showing results (11-20 of 69) with videos related to
Page
of 7
Sort By:
American Journal of Preventive Cardiology
|
February 3, 2025
Biomarkers of residual risk and all-cause mortality after acute coronary syndrome
Anna Toso, Mario Leoncini, Mauro Maioli, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
November 27, 2019
Restrictive filling pattern in ischemic cardiomyopathy: Insights after surgical ventricular restoration
Fabio Fantini, Anna Toso, Lorenzo Menicanti, et al.
Circulation. Cardiovascular Interventions
|
October 6, 2011
Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial
Mauro Maioli, Anna Toso, Mario Leoncini, et al.
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology
|
November 12, 2005
[Sirolimus-eluting stent for in-stent restenosis treatment: single center results in an unselected study population]
Francesco Bellandi, Anna Toso, Mauro Maioli, et al.
Journal of the American College of Cardiology
|
April 10, 2007
Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial)
Mauro Maioli, Francesco Bellandi, Mario Leoncini, et al.
International Journal of Cardiology
|
June 2, 2005
Early abciximab administration in acute myocardial infarction treated with primary coronary intervention
Francesco Bellandi, Mauro Maioli, Mario Leoncini, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
June 2, 2004
Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention
Francesco Bellandi, Mauro Maioli, Michela Gallopin, et al.
Cardiorenal Medicine
|
May 21, 2020
A Prospective, Randomized, Open-Label Trial of Atorvastatin versus Rosuvastatin in the Prevention of Contrast-Induced Acute Kidney Injury, Worsened Renal Function at 30 Days, and Clinical Events After Acute Coronary Angiography: the PRATO-ACS-2 Study
Anna Toso, Mario Leoncini, Mauro Maioli, et al.
Journal of the American College of Cardiology
|
October 1, 2013
Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome)
Mario Leoncini, Anna Toso, Mauro Maioli, et al.
Circulation
|
May 18, 2012
Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis
Mauro Maioli, Anna Toso, Mario Leoncini, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 69) with videos related to
Sort By:
Page
of 7
American Journal of Preventive Cardiology
|
February 3, 2025
Biomarkers of residual risk and all-cause mortality after acute coronary syndrome
Anna Toso, Mario Leoncini, Mauro Maioli, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
November 27, 2019
Restrictive filling pattern in ischemic cardiomyopathy: Insights after surgical ventricular restoration
Fabio Fantini, Anna Toso, Lorenzo Menicanti, et al.
Circulation. Cardiovascular Interventions
|
October 6, 2011
Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial
Mauro Maioli, Anna Toso, Mario Leoncini, et al.
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology
|
November 12, 2005
[Sirolimus-eluting stent for in-stent restenosis treatment: single center results in an unselected study population]
Francesco Bellandi, Anna Toso, Mauro Maioli, et al.
Journal of the American College of Cardiology
|
April 10, 2007
Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial)
Mauro Maioli, Francesco Bellandi, Mario Leoncini, et al.
International Journal of Cardiology
|
June 2, 2005
Early abciximab administration in acute myocardial infarction treated with primary coronary intervention
Francesco Bellandi, Mauro Maioli, Mario Leoncini, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
June 2, 2004
Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention
Francesco Bellandi, Mauro Maioli, Michela Gallopin, et al.
Cardiorenal Medicine
|
May 21, 2020
A Prospective, Randomized, Open-Label Trial of Atorvastatin versus Rosuvastatin in the Prevention of Contrast-Induced Acute Kidney Injury, Worsened Renal Function at 30 Days, and Clinical Events After Acute Coronary Angiography: the PRATO-ACS-2 Study
Anna Toso, Mario Leoncini, Mauro Maioli, et al.
Journal of the American College of Cardiology
|
October 1, 2013
Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome)
Mario Leoncini, Anna Toso, Mauro Maioli, et al.
Circulation
|
May 18, 2012
Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis
Mauro Maioli, Anna Toso, Mario Leoncini, et al.
Page
of 7